Evidence map›Paper›PMID 42163407›Full record

ArticleAntimicrobial resistance and infection control2026

Impact of targeted infection prevention and control interventions on bloodstream infections and colonization with carbapenem-resistant organisms among hospitalized neonates, Bangladesh, 2023-2024.

Ashley Styczynski, Amelia Keaton, Gazi Md Salahuddin Mamun, Sanzida Khan, Shariful Amin Sumon, Tanzir Ahmed Shuvo, Shabrina Sharmin, Md Aminul Islam, Aninda Rahman, Tahsinul Amin and 9 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ashley StyczynskiDivision of Healthcare Quality and Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. yxn2@cdc.gov.
Amelia KeatonDivision of Healthcare Quality and Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gazi Md Salahuddin MamunInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Sanzida KhanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Shariful Amin SumonInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Tanzir Ahmed ShuvoInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Shabrina SharminInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Md Aminul IslamInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Aninda RahmanDirectorate General of Health Services, Ministry of Health and Family Welfare, Dhaka, Bangladesh.
Tahsinul AminDepartment of Neonatology, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Jesmin AkterDepartment of Neonatology, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Kakali HalderDepartment of Microbiology, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Sazzad Bin ShahidDepartment of Microbiology, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Gemma ParraDivision of Healthcare Quality and Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lisa P OakleyDivision of Infectious Disease Readiness and Innovation, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Katie WilsonDivision of Healthcare Quality and Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Molly PatrickDivision of Healthcare Quality and Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Md Golam Dostogir HarunInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Fahmida ChowdhuryInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Fahmida_chow@icddrb.org.

Funding

TEPHINET GH000044
6 · The paper itself

Abstract

backgroundNeonates admitted to neonatal intensive care units (NICUs) are particularly susceptible to acquiring healthcare-associated infections because of factors such as prematurity, prolonged hospital stays, and need for invasive support devices. A longitudinal study in a Bangladeshi NICU demonstrated a high burden of bloodstream infections (BSIs) and rectal colonization with carbapenem-resistant organisms (CROs). We aimed to assess the impact of infection prevention and control (IPC) interventions on BSIs and CRO colonization in this NICU.

methodsWe conducted a quasi-experimental study in a 38-bed NICU of a tertiary care referral hospital in Dhaka, Bangladesh. Following a baseline assessment in December 2023-January 2024, an IPC intervention was carried out during February-September 2024, with a pause during June-August because of political instability. NICU staff, including environmental cleaners, received multimodal IPC training with an emphasis on hand hygiene and environmental cleaning. Compliance was monitored through covert observation of hand hygiene and use of fluorescent markers on environmental surfaces. Colonization with CROs was evaluated through twice monthly point prevalence surveys using rectal swabs plated on selective media followed by Vitek 2 confirmatory testing. BSIs were assessed based on recovery of pathogenic organisms from blood cultures, and mortality rates were determined based on the number of deaths per 100 admissions. We assessed for trends in process and outcome measures over time using the Mann-Kendall test.

resultsOver the course of the IPC intervention, hygiene compliance improved from 13% to 69% (p < 0.001) while environmental cleaning improved from 10% to 87% (p < 0.001). We sampled 363 neonates across 12 point prevalence surveys. CRO colonization was similar at the beginning of the intervention compared with the endline (88% vs. 81%, p = 0.45). However, BSI incidence decreased from 28 to 4 per 100 admissions (p = 0.034), representing an 86% reduction. Similarly, mortality decreased from 26 to 4 per 100 admissions (p = 0.064), though this change was not statistically significant.

conclusionsEnhancing basic IPC practices may be effective in reducing adverse outcomes in low-resource settings with a high burden of multidrug-resistant organisms (MDROs). However, the lack of impact on CRO colonization suggests the need for additional IPC and/or antibiotic stewardship interventions to further mitigate MDRO transmission and the selective pressures driving MDRO proliferation in this NICU.

Indexed as

BacteremiaCross InfectionInfection ControlSepsisBangladeshCarbapenemsFemaleHumansInfant, NewbornIntensive Care Units, NeonatalLongitudinal StudiesMaleCarbapenems

Identifiers

PMID42163407
PMCPMC13242672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.